Wockhardt Ltd — Regulatory Filings 2020

Apr 16, 2020

==> picture [162 x 45] intentionally omitted <==

16[th] April, 2020

BSE LimitedCorporate Relations DepartmentP J Towers,Dalal StreetMumbai - 400 001Scrip Code: 532300		National Stock Exchange of India LimitedListing DepartmentExchange PlazaBandra Kurla Complex, Bandra (E),Mumbai - 400 051NSE Symbol– WOCKPHARMA

Dear Sir/ Madam,

Sub: Clarification on movement in price

This is with reference to your communication dated 15[th] April, 2020/ 16[th] April, 2020 about movement in share price of the Company.

In this regard, we have to inform you that the Company has been making prompt disclosures of all events or information that have bearing on the operation / performance of the Company which includes all price sensitive information as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

At this point of time, the Company does not have any specific information/ announcement which have a bearing on the price or volume behavior of the scrip. Please note that the Company submits the requisite disclosures to the Stock Exchanges and shall continue to do so as part of its obligation under Regulation 30 of the SEBI Listing Regulations or other relevant applicable laws.

Kindly take the same on record.

Thanking you,

for Wockhardt Limited

==> picture [91 x 42] intentionally omitted <==

Narendra Singh Company Secretary

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==